<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>treatment - PiNSA Members</title>
	<atom:link href="https://pinsa.org.za/members/tag/treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://pinsa.org.za/members</link>
	<description>Primary Immunodeficiency Network of South Africa</description>
	<lastBuildDate>Thu, 10 Apr 2025 18:01:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.2</generator>
	<item>
		<title>Sub-Q IG Administration-Freedom60 Pump</title>
		<link>https://pinsa.org.za/members/sub-q-ig-administration-freedom60-pump/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=sub-q-ig-administration-freedom60-pump</link>
		
		<dc:creator><![CDATA[info@pinsa.org.za]]></dc:creator>
		<pubDate>Thu, 10 Apr 2025 18:01:49 +0000</pubDate>
				<category><![CDATA[Nurses' Corner]]></category>
		<category><![CDATA[IPOPI]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=4313</guid>

					<description><![CDATA[<p>Sub-Q IG Administration-Freedom60 Pump</p>
<p>The post <a href="https://pinsa.org.za/members/sub-q-ig-administration-freedom60-pump/">Sub-Q IG Administration-Freedom60 Pump</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Rheumatological, Autoimmune and Autoinflammatory Crossovers</title>
		<link>https://pinsa.org.za/members/rheumatological-autoimmune-autoinflammatory-crossovers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=rheumatological-autoimmune-autoinflammatory-crossovers</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Sat, 11 Mar 2023 09:00:22 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[autoimmune]]></category>
		<category><![CDATA[autoinflammatory]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[IPOPI]]></category>
		<category><![CDATA[rheumatological]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2678</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Targeted Therapies for PIDs</title>
		<link>https://pinsa.org.za/members/targeted-therapies-for-pids/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=targeted-therapies-for-pids</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Sat, 11 Mar 2023 08:56:15 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[immunoglobulin therapy]]></category>
		<category><![CDATA[IPOPI]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2676</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>PIDS and the Skin</title>
		<link>https://pinsa.org.za/members/pids-and-the-skin/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pids-and-the-skin</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Fri, 10 Mar 2023 12:57:26 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[IPOPI]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[skin]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2650</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Recommendations on Vaccinations in Immunocompromised Patients 2014</title>
		<link>https://pinsa.org.za/members/vaccinations-in-immunocompromised-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vaccinations-in-immunocompromised-patients</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Mon, 06 Mar 2023 12:50:35 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[vaccinations]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2524</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>UK Clinical Guidelines For Immunoglobulin Use 2011</title>
		<link>https://pinsa.org.za/members/clinical-guidelines-immunoglobulin-use/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=clinical-guidelines-immunoglobulin-use</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Mon, 06 Mar 2023 12:26:45 +0000</pubDate>
				<category><![CDATA[Clinical Guidelines]]></category>
		<category><![CDATA[clinical guidelines]]></category>
		<category><![CDATA[immunoglobulins]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2520</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index 2021</title>
		<link>https://pinsa.org.za/members/pid-principles-of-care/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pid-principles-of-care</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Mon, 06 Mar 2023 12:06:58 +0000</pubDate>
				<category><![CDATA[Healthcare Professionals]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[principles of care]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2511</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee</title>
		<link>https://pinsa.org.za/members/human-inborn-errors-of-immunity/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=human-inborn-errors-of-immunity</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Mon, 06 Mar 2023 11:57:18 +0000</pubDate>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[human inborn errors of immunity]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2504</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Frequently Asked Questions</title>
		<link>https://pinsa.org.za/members/faq/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=faq</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Sun, 05 Mar 2023 08:28:29 +0000</pubDate>
				<category><![CDATA[Frequently Asked Questions]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[frequently asked questions]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[medical advisory panel]]></category>
		<category><![CDATA[patient toolkit]]></category>
		<category><![CDATA[PID]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://pinsa.org.za/members/?p=2496</guid>

					<description><![CDATA[<p>Updated by our Medical Advisory Panel March 2023</p>
<p>The post <a href="https://pinsa.org.za/members/faq/">Frequently Asked Questions</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Report any adverse reactions to IG products</title>
		<link>https://pinsa.org.za/members/report-any-adverse-reactions-to-ig-products/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=report-any-adverse-reactions-to-ig-products</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Fri, 19 Jul 2019 13:54:41 +0000</pubDate>
				<category><![CDATA[Healthcare Professionals]]></category>
		<category><![CDATA[adverse reactions]]></category>
		<category><![CDATA[immunoglobulins]]></category>
		<category><![CDATA[report]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://www.pinsa.org.za/?p=1306</guid>

					<description><![CDATA[<p>To all our members It is vital that you, or your treating doctor/nurse use this form to notify SAHPRA of any adverse reaction that you might have from using IG products. This information is vital for several reasons including the following: You can report an adverse event even if you are not certain that it...</p>
<p>The post <a href="https://pinsa.org.za/members/report-any-adverse-reactions-to-ig-products/">Report any adverse reactions to IG products</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>IDF Diagnostic and Clinical Care Guidelines for Primary Immunodeficiency Diseases 2015</title>
		<link>https://pinsa.org.za/members/diagnostic-and-clinical-care-guidelines-for-primary-immunodeficiency-diseases/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=diagnostic-and-clinical-care-guidelines-for-primary-immunodeficiency-diseases</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Sun, 19 Jul 2015 14:25:09 +0000</pubDate>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[clinical guidelines]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://www.pinsa.org.za/?p=1102</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>Prevention of Infections during Primary Immunodeficiency 2014</title>
		<link>https://pinsa.org.za/members/prevention-of-infections-during-primary-immunodeficiency/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=prevention-of-infections-during-primary-immunodeficiency</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Sat, 15 Nov 2014 13:07:10 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[immunisations]]></category>
		<category><![CDATA[immunoglobulins]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[prophylaxis]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://www.pinsa.org.za/?p=962</guid>

					<description><![CDATA[]]></description>
		
		
		
			</item>
		<item>
		<title>IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency</title>
		<link>https://pinsa.org.za/members/ipopi-position-statement-access-to-immunoglobulin-therapies-for-patients-living-with-a-primary-immunodeficiency/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ipopi-position-statement-access-to-immunoglobulin-therapies-for-patients-living-with-a-primary-immunodeficiency</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Mon, 29 Sep 2014 18:45:13 +0000</pubDate>
				<category><![CDATA[Position Statements]]></category>
		<category><![CDATA[immunoglobulins]]></category>
		<category><![CDATA[IPOPI]]></category>
		<category><![CDATA[position statement]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://pinsa.wildleim.com/?p=623</guid>

					<description><![CDATA[<p>8 May 2012 This statement is intended to provide a summary of IPOPI’s position with regards to the importance of ensuring access for patients living with a primary immunodeficiency (PID) to the best suited immunoglobulin (IG) replacement therapy, as selected and prescribed by their physician. IPOPI is concerned by recent developments in several countries that...</p>
<p>The post <a href="https://pinsa.org.za/members/ipopi-position-statement-access-to-immunoglobulin-therapies-for-patients-living-with-a-primary-immunodeficiency/">IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Antibiotics and Primary Immunodeficiencies</title>
		<link>https://pinsa.org.za/members/antibiotics-and-pids/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=antibiotics-and-pids</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Tue, 09 Sep 2014 13:22:34 +0000</pubDate>
				<category><![CDATA[Clinical Guidelines]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://pinsa.wildleim.com/?p=436</guid>

					<description><![CDATA[<p>Antibiotics are important medicines for managing and treating infections caused by bacteria.  This information is for primary immunodeficiency patients and their carers aims to help ensure antibiotics are used safely and effectively. What are antibiotics? Antibiotics are medicines used to treat infections caused by bacteria, one of the important families of bugs that cause illness....</p>
<p>The post <a href="https://pinsa.org.za/members/antibiotics-and-pids/">Antibiotics and Primary Immunodeficiencies</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Gene therapy</title>
		<link>https://pinsa.org.za/members/gene-therapy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=gene-therapy</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Tue, 09 Sep 2014 13:21:07 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[gene therapy]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://pinsa.wildleim.com/?p=434</guid>

					<description><![CDATA[<p>Great advances made in the last ten years mean that the use of gene therapy to treat and cure primary immunodeficiencies (PIDs) is a reality. What is gene therapy? Gene therapy is a ‘mini gene transplant’. Doctors remove stem cells from the patient with a PID, replace the defective genes inside the cells with new,...</p>
<p>The post <a href="https://pinsa.org.za/members/gene-therapy/">Gene therapy</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Bone marrow transplantation</title>
		<link>https://pinsa.org.za/members/bone-marrow-transplantation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bone-marrow-transplantation</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Tue, 09 Sep 2014 13:19:06 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[primary immunodeficiency]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://pinsa.wildleim.com/?p=431</guid>

					<description><![CDATA[<p>Bone marrow transplantation (BMT) is a cure for many primary immunodeficiency (PID) conditions. In the last 20 years there have been huge advances in success and survival rates and in the range of conditions that can be treated by BMT. What is bone marrow? Bone marrow is the soft, spongy tissue found in the centre of bones. It...</p>
<p>The post <a href="https://pinsa.org.za/members/bone-marrow-transplantation/">Bone marrow transplantation</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Immunoglobulin therapy</title>
		<link>https://pinsa.org.za/members/immunoglobulin-therapy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=immunoglobulin-therapy</link>
		
		<dc:creator><![CDATA[PiNSA]]></dc:creator>
		<pubDate>Tue, 09 Sep 2014 13:17:14 +0000</pubDate>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[immunoglobulin therapy]]></category>
		<category><![CDATA[immunoglobulins]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">http://pinsa.wildleim.com/?p=429</guid>

					<description><![CDATA[<p>If you have any other queries about immunoglobulin therapy you would like answers to, please contact us. What is immunoglobulin replacement therapy? Immunoglobulin (IG) replacement therapy is a blood-based treatment. The immunoglobulin contains antibodies which will help fight infection. You have been recommended this treatment because your doctors have found that your immune system (or your...</p>
<p>The post <a href="https://pinsa.org.za/members/immunoglobulin-therapy/">Immunoglobulin therapy</a> first appeared on <a href="https://pinsa.org.za/members">PiNSA Members</a>.</p>]]></description>
		
		
		
			</item>
	</channel>
</rss>
